US Stock MarketDetailed Quotes

CTMX CytomX

Watchlist
  • 0.930
  • +0.062+7.17%
Trading Jan 24 12:09 ET
72.78MMarket Cap5.81P/E (TTM)

About CytomX Company

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

Company Profile

SymbolCTMX
Company NameCytomX
Listing DateOct 8, 2015
Issue Price12.00
Founded2010
CEODr. Sean A. McCarthy, D.Phil.
MarketNASDAQ
Employees122
Fiscal Year Ends12-31
Address151 Oyster Point Boulevard,Suite 400
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080-1913
Phone1-605-515-3185
Websitehttp://www.cytomx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sean A. McCarthy, D.Phil.
  • Chief Executive Officer and Chairman of the Board
  • 2.61M
  • Jeffrey B. Landau
  • Senior Vice President, Chief Business Officer, and Head of Strategy
  • 1.05M
  • Christopher W. Ogden
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Marcia Belvin
  • Senior Vice President and Chief Scientific Officer
  • 1.21M
  • Dr. Alan Ashworth
  • Independent Director
  • 69.12K
  • Matthew P. Young
  • Lead Independent Director
  • 105.12K
  • Dr. Mani Mohindru, PhD
  • Independent Director
  • 78.62K
  • James R. Meyers
  • Independent Director
  • 77.12K
  • Halley E. Gilbert
  • Independent Director
  • 80.62K
  • Dr. Elaine V. Jones, PhD
  • Independent Director
  • 75.12K
  • Dr. Zhen Su
  • DIrector
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
GVS
870976
+29.98%
Hangzhou CNCR-IT
300250
+20.03%
Shanghai Newtouch Software
688590
+20.01%
4
Ucap Cloud Information Technology Co.,Ltd
688228
+20.00%
5
Yangtze Optical Electronic
688143
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks Show More
Ask a strategist - Trump's first day
China Concept Stocks
Tracking the US-listed Chinese companies.